Current trends in quantitative structure-activity relationship validation and applications on drug discovery (2017)
- Authors:
- USP affiliated authors: HONORIO, KÁTHIA MARIA - EACH ; WRENGER, CARSTEN - ICB
- Unidades: EACH; ICB
- DOI: 10.4155/fsoa-2017-0052
- Subjects: RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA; PLANEJAMENTO DE FÁRMACOS; FÁRMACOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Future Science OA
- ISSN: 2056-5623
- Volume/Número/Paginação/Ano: v. 3, n. 4, p. FSO214-FSO216, jul. 2017
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MALTAROLLO, Vinicius G. et al. Current trends in quantitative structure-activity relationship validation and applications on drug discovery. Future Science OA, v. 3, n. 4, p. FSO214-FSO216, 2017Tradução . . Disponível em: https://doi.org/10.4155/fsoa-2017-0052. Acesso em: 13 fev. 2026. -
APA
Maltarollo, V. G., Kronenberger, T., Wrenger, C., & Honorio, K. M. (2017). Current trends in quantitative structure-activity relationship validation and applications on drug discovery. Future Science OA, 3( 4), FSO214-FSO216. doi:10.4155/fsoa-2017-0052 -
NLM
Maltarollo VG, Kronenberger T, Wrenger C, Honorio KM. Current trends in quantitative structure-activity relationship validation and applications on drug discovery [Internet]. Future Science OA. 2017 ; 3( 4): FSO214-FSO216.[citado 2026 fev. 13 ] Available from: https://doi.org/10.4155/fsoa-2017-0052 -
Vancouver
Maltarollo VG, Kronenberger T, Wrenger C, Honorio KM. Current trends in quantitative structure-activity relationship validation and applications on drug discovery [Internet]. Future Science OA. 2017 ; 3( 4): FSO214-FSO216.[citado 2026 fev. 13 ] Available from: https://doi.org/10.4155/fsoa-2017-0052 - On the relationship of anthranilic derivatives structure and the FXR (Farnesoid X receptor) agonist activity
- Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses
- Advances and challenges in drug design of PPARδ ligands
- Oxidative stress in human infectious diseases - present and current - knowledge about its druggability
- Purification, crystallization and preliminary X-ray diffraction analysis of pyridoxal kinase from Plasmodium falciparum (PfPdxK)
- Exploring inhibition of Pdx1, a component of the PLP synthase complex of the human malaria parasite Plasmodium falciparum
- Trafficked Proteins—Druggable in Plasmodium falciparum?
- In vitro activity of extracts and isolated polyphenols from West African medicinal plants against Plasmodium falciparum
- Oxidative stress control by apicomplexan parasites
- Identification of a non-competitive inhibitor of Plasmodium falciparum aspartate transcarbamoylase
Informações sobre o DOI: 10.4155/fsoa-2017-0052 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
